The following HTML text is provided to enhance online
readability. Many aspects of typography translate only awkwardly to HTML.
Please use the page image
as the authoritative form to ensure accuracy.
Preventing Medication Errors
variation in error rates across facilities. The few existing studies ofthe costs associated with medication errors are limited to the healthcare costs incurred by preventable injuries, and these are substantial.
At least a quarter of all medication-related injuries are preventable. Many efficacious error prevention strategies are available,especially for hospital care; examples are electronic prescribing andclinical decision-support systems that check dosages and monitorfor harmful drug–drug interactions. This report provides guidanceon how to implement error prevention strategies in hospitals, long-term care, and ambulatory care.
Establishing and maintaining a strong provider–patient partnership is a key approach for reducing medication errors. Thereport outlines how such a partnership can be achieved and whatroles providers, patients, and third parties must play. For example,consumers should maintain careful records of their medications,providers should review a patient’s list of medications at each encounter and at times of transition between care settings (e.g., hospital to outpatient care), and the federal government should seekways to improve the quality of pharmacy leaflets and medication-related information on the Internet for consumers.
Health care providers in all settings should seek to create high-reliability organizations that constantly improve the safety andquality of medication use. To this end, they should implementactive internal monitoring programs so that progress toward improved medication safety can be accurately demonstrated. The report offers guidance on appropriate monitoring systems for eachmajor care setting.
In carrying out this study, the IOM committee identified enormous gaps in the knowledge base with regard to medication errors.Current methods for generating and communicating informationabout medications are inadequate and contribute to the incidenceof errors. Likewise, incidence rates of medication errors in manycare settings, the costs of such errors, and the efficacy of preventionstrategies are not well understood. The report proposes a researchagenda to address these and other knowledge gaps.
The Institute of Medicine (IOM) report To Err Is Human: Building aSafer Health System (IOM, 2000) accelerated existing efforts to prevent medication errors and improve the quality of health care, efforts that are just now gaining acceptance as a discipline requiring investment in individuals who specialize in error prevention and quality improvement. Against this background, at the urging of the Senate Finance Committee, the United States